SCALETTI, FEDERICA
 Distribuzione geografica
Continente #
NA - Nord America 1.167
EU - Europa 625
AS - Asia 124
AF - Africa 3
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 1.921
Nazione #
US - Stati Uniti d'America 1.164
PL - Polonia 264
IT - Italia 114
IE - Irlanda 87
CN - Cina 60
SE - Svezia 58
HK - Hong Kong 49
GB - Regno Unito 31
FI - Finlandia 20
DE - Germania 14
UA - Ucraina 14
BE - Belgio 12
JO - Giordania 6
ES - Italia 4
FR - Francia 4
CA - Canada 3
EG - Egitto 3
IN - India 3
VN - Vietnam 3
NL - Olanda 2
TR - Turchia 2
CH - Svizzera 1
EU - Europa 1
KR - Corea 1
NZ - Nuova Zelanda 1
Totale 1.921
Città #
Warsaw 264
Fairfield 203
Woodbridge 123
Chandler 113
Ashburn 87
Dublin 87
Ann Arbor 82
Seattle 77
Houston 72
Cambridge 61
Wilmington 61
Florence 45
Beijing 40
Hong Kong 32
Lawrence 29
Princeton 28
Altamura 27
Buffalo 23
Jacksonville 18
Boston 17
Boardman 13
Brussels 12
Medford 10
San Diego 9
Shanghai 9
Barcelona 4
Bologna 4
Cagliari 4
Falls Church 4
London 4
New York 4
Shenzhen 4
Dong Ket 3
Fuzhou 3
New Delhi 3
Norwalk 3
Toronto 3
Andover 2
Bremen 2
Cairo 2
Dearborn 2
Istanbul 2
Los Angeles 2
Romainville 2
Shenyang 2
Verona 2
West Jordan 2
Auburn Hills 1
Auckland 1
Bochum 1
Campi Bisenzio 1
Cedar Knolls 1
Chieti 1
Fossalunga 1
Frankfurt Am Main 1
Genova 1
Hangzhou 1
Hillsboro 1
Huzhou 1
Kent 1
Laurel 1
Modena 1
Monticiano 1
Nürnberg 1
Phoenix 1
Piacenza 1
Prato 1
Quartu Sant'elena 1
Redmond 1
Redwood City 1
Rotterdam 1
Scandicci 1
Serra 1
Tappahannock 1
Trumbull 1
Vicchio 1
Vigevano 1
Totale 1.635
Nome #
Proteomic analysis of A2780/S ovarian cancer cell response to the cytotoxic organogold(III) compound Aubipy(c.) 210
Engineering Gold Nanorods for Cancer Treatment: Biological Profile, Protein Interactions and Drug Delivery. 202
Reactions of model proteins with aurothiomalate, a clinically established gold(I) drug: The comparison with auranofin 125
Chemistry and Biology of Two Novel Gold(I) Carbene Complexes as Prospective Anticancer Agents 104
Metal-Based Compounds as Prospective Antileishmanial Agents: Inhibition of Trypanothione Reductase by Selected Gold Complexes 101
Water-soluble Ru(II)- and Ru(III)-halide-PTA complexes (PTA = 1,3,5-triaza-7-phosphaadamantane): Chemical and biological properties 100
null 93
{Ru(CO)x}-core complexes with selected azoles: Synthesis, X-ray structure, spectroscopy, DFT analysis and evaluation of cytotoxic activity against human cancer cells 91
The mode of action of anticancer gold-based drugs: a structural perspective 86
Chemistry and biology of three representative gold(III) compounds as prospective anticancer agents 81
Interactions of the organogold(III) compound Aubipyc with the copper chaperone Atox1: A joint mass spectrometry and circular dichroism investigation 76
NAMI-A is highly cytotoxic toward leukaemia cell lines: evidence of inhibition of KCa 3.1 channels 74
Size dependent biological profiles of PEGylated gold nanorods 71
null 68
Tuning the interactions of PEG-coated gold nanorods with BSA and model proteins through insertion of amino or carboxylate groups 64
Ru(CO)x-Core complexes with benzimidazole ligands: synthesis, X-ray structure and evaluation of anticancer activity in vivo 62
Interactions of Gold-based drugs with proteins: crystal structure of the adduct formed between Ribonuclease A and a cytotoxic gold(III) compound 61
New platinum(II) and palladium(II) complexes with substituted terpyridine ligands: synthesis and characterization, cytotoxicity and reactivity towards biomolecules 54
Gold compounds: new anticancer drugs candidates. Studies of protein metalation processes 34
The fate of differently functionalized gold nanorods in human serum: A response from capillary electrophoresis–inductively coupled plasma mass spectrometry 32
null 31
Rapid purification of gold nanorods for biomedical applications 31
Studies of cytotoxic gold compounds: interactions with model proteins and with the copper chaperone Atox-1 25
Mechanistic studies on cytotoxic gold compounds 24
null 21
Medicinal gold compounds form tight adducts with the copper chaperone Atox-1: biological and pharmacological implications 21
Protein metalation by metal-based drugs: reactions of cytotoxic gold compounds with cytochrome c and lysozyme 17
Totale 1.959
Categoria #
all - tutte 5.443
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.443


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019144 0 0 0 0 0 0 0 0 0 0 77 67
2019/2020481 39 35 24 30 51 50 49 58 50 32 50 13
2020/2021222 16 29 8 22 13 43 8 15 22 22 8 16
2021/2022170 3 15 13 6 5 6 8 13 6 13 33 49
2022/2023439 50 100 30 32 28 71 57 22 29 0 18 2
2023/2024131 8 17 25 4 8 14 5 39 3 6 2 0
Totale 1.959